Your Subtitle text
Home Page
Vaxiion is dedicated to the intelligent design of effective vaccines and vaccine carrier technologies. Recent events surrounding bioterrorism, emerging infectious diseases, and the development of multidrug resistance in many types of human pathogens have led to the conclusion that new vaccine development is desperately needed. Vaxiion's unique approach is to use genetically engineered non-living bacterial minicells to deliver a multitude of protein antigens and DNA vaccines for a variety of pathogens and disease indications. The company is using its proprietary technologies, anti-microbial and immunological expertise to develop and validate the minicell delivery technology for use in several product applications. Vaxiion's proprietary minicell-based vaccines have shown efficacy in pre-clinical animal models.
"Intelligent design of effective vaccines"
Another Western States Investment Group Portfolio Company